Integrating Primary & Secondary Interventions for Cervical Cancer Prevention in Primary Care Settings

Completed · Not applicable

Conditions studied: HPV-Related Carcinoma

In brief

The purpose of this study is to determine whether a mobile health educational intervention for Human PapillomaVirus (HPV) Vaccination promotion and cervical cancer screening in Primary Care settings is a feasible behavioral intervention to integrate as a primary and secondary cervical cancer prevention approach.Study Design: The investigators will conduct an open feasibility proof-of-concept trial using a single experimental group with all subjects receiving the behavioral intervention being studied. Outcome measures. The primary outcome of interest is receipt of the first dose and completion of the three-dose series of HPV vaccine within 6 month of intervention, this will be evaluated by Electronic medical review review.

Key facts

Study ID

NCT03033550

Run by

Boston Medical Center

People needed

100

Starts

2017-05-08

Expected to finish

2018-06-08

Last updated by the study team

2018-07-09

Who can join

Age: 9 and older, up to 17. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• AFG ages 30 years and older who receive primary care at the study sites.
• AFG consent to have cervical cancer screening status checked in Electronic Medical Record.
• AFG has a daughter between the ages of 11 to 17 who receive primary care at either
• Family Medicine or Pediatric and Adolescent primary care clinic at Boston Medical Center.
• AFG consent to have daughter's HPV vaccination status checked in Electronic Medical Record.
• AFG's daughter has neither initiated the HPV vaccine nor completed the three vaccine series
• AFG and daughter have the ability to read and write in English.
• AFG and daughter each have a cell phone with text messages capabilities.

You may not qualify if…

• The investigators will exclude based on the following criteria:
• AFG being seen for a sick visit.
• AFG has an adolescent daughter who is pregnant or is a mother.
• AFG has a daughter who has completed the three dose HPV vaccine series.
• AFG, in the opinion of the clinical staff, is cognitively impaired and unable to give informed consent and may not participate.

Where it is running

• Boston Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.